SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-038114
Filing Date
2024-03-28
Accepted
2024-03-28 16:36:59
Documents
29
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A lbph-20240328.htm   iXBRL PRE 14A 718785
2 GRAPHIC img10438024_0.jpg GRAPHIC 111121
3 GRAPHIC img10438024_1.jpg GRAPHIC 40943
4 GRAPHIC img10438024_2.jpg GRAPHIC 45187
5 GRAPHIC img10438024_3.jpg GRAPHIC 43606
6 GRAPHIC img10438024_4.jpg GRAPHIC 44689
7 GRAPHIC img10438024_5.jpg GRAPHIC 48997
8 GRAPHIC img10438024_6.jpg GRAPHIC 44303
9 GRAPHIC img10438024_7.jpg GRAPHIC 42688
10 GRAPHIC img10438024_8.jpg GRAPHIC 42350
11 GRAPHIC img10438024_9.jpg GRAPHIC 227774
12 GRAPHIC img10438024_10.jpg GRAPHIC 25180
13 GRAPHIC img10438024_11.jpg GRAPHIC 17373
14 GRAPHIC img10438024_12.jpg GRAPHIC 78485
15 GRAPHIC img10438024_13.jpg GRAPHIC 67951
16 GRAPHIC img10438024_14.jpg GRAPHIC 46758
17 GRAPHIC img10438024_15.jpg GRAPHIC 46101
18 GRAPHIC img10438024_16.jpg GRAPHIC 290506
19 GRAPHIC img10438024_17.jpg GRAPHIC 144423
  Complete submission text file 0000950170-24-038114.txt   4419402

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20240328.xsd EX-101.SCH 8107
32 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20240328_htm.xml XML 1309
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40192 | Film No.: 24799767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)